Catamaran receives Specialty Pharmacy Accreditation from URAC for BriovaRx Catamaran Corp.C.-structured accrediting organization that establishes quality standards for the healthcare industry . ‘BriovaRx's robust offerings concentrate on the individual, ensuring one-on-a single support and a personalized plan that addresses chronic conditions to greatly help them lead healthy, lively lives,’ said Tag Thierer , CEO and Chairman of Catamaran.

Catalyst funded the transaction with a combined mix of cash readily available and amounts obtainable under its credit facility. ‘We have been pleased with the integration preparing and are highly assured that the Company will rapidly realize the countless strategic and financial great things about this transaction,’ stated David T. Blair, CEO of Catalyst. THE BUSINESS will issue another press release and conduct a special investor conference ask July 7, 2011 to go over the WHI acquisition and offer updated 2011 financial guidance further.

Other entries from category "mycology":

Random entries